BIOFIRE FILMARRAY Pneumonia Panel Recalled for Manufacturing Defect
BioFire Diagnostics is recalling 58 units of BIOFIRE FILMARRAY Pneumonia Panel due to a manufacturing defect that increases the risk of control failures and delayed test results.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves a manufacturing defect affecting diagnostic test control, creating a risk of delayed test results in pneumonia diagnosis. No illnesses or injuries are reported, making this a theoretical risk-of-harm scenario that meets the High criterion for products where injury has not yet been reported.
Plain-English summary
BioFire Diagnostics, LLC is recalling the BIOFIRE FILMARRAY Pneumonia Panel (REF: RFIT-ASY-0144) due to a manufacturing process defect. The affected product comprises 58 units distributed worldwide, including the US states of West Virginia, Indiana, and Alabama, as well as France, Italy, Spain, Greece, Japan, Singapore, Chile, Taiwan, Israel, Romania, Ecuador, and Serbia.
The manufacturing defect creates an increased risk of control failures in the pneumonia panel. Control failures could lead to delayed test results, which may impact timely clinical decision-making and patient care.
Healthcare facilities and laboratories that received this product should verify whether they have units bearing lot numbers 2147623 (expiration 28-Aug-2024) or 2147523 (expiration 27-Aug-2024). Contact BioFire Diagnostics for instructions regarding affected units in your facility.
The recalled product
- Product
- BIOFIRE FILMARRAY Pneumonia Panel, REF: RFIT-ASY-0144
- Manufacturer
- BioFire Diagnostics, LLC
- Affected units
- 58
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- UDI-DI: 00815381020178. Lot/Expiration: 2147623/28-Aug-2024
- 2147523/27-Aug-2024
Distribution
Part of a larger recall action
This product is one of 2 recalled by BioFire Diagnostics, LLC under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · BioFire Diagnostics, LLC
See all →- HighBioFire Respiratory Panel 2.1 Recalled for Increased False Negative Results
FDA (Devices) · 2026-08-19
- HighBioFire Joint Infection Panel diagnostic test kit contamination recall
FDA (Devices) · 2026-05-13
- HighBioFire Spotfire Respiratory/Sore Throat Panel Recall for False Negatives
FDA (Devices) · 2026-05-13
- HighRespiratory test panels recalled over elevated risk of false negative results
FDA (Devices) · 2025-12-03
- HighBioFire Respiratory Panel 2.1 plus Kit recalled for manufacturing defect
FDA (Devices) · 2025-06-04
Same hazard · control failure
See all →- HighPhilips MultiDiagnost Eleva hand switch buttons may not fully release
FDA (Devices) · 2026-06-24
- HighPhilips Allura Xper hand switch buttons may not fully release
FDA (Devices) · 2026-06-24
- HighPositive control serum recalled over negative recovery of the HBsAg analyte
FDA (Devices) · 2025-11-19
- HighSecond control serum lot recalled over negative HBsAg analyte recovery
FDA (Devices) · 2025-11-19
- ModerateFilmArray NGDS Warrior Panel diagnostic test system recall notice
FDA (Devices) · 2025-10-01